EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 105 filers reported holding EIDOS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,195,000 | +237.6% | 9,072 | +29.4% | 0.00% | – |
| Q3 2020 | $354,000 | +19.2% | 7,010 | +12.2% | 0.00% | – |
| Q2 2020 | $297,000 | +53.1% | 6,245 | +57.4% | 0.00% | – |
| Q1 2020 | $194,000 | -26.0% | 3,967 | -13.5% | 0.00% | – |
| Q4 2019 | $262,000 | +138.2% | 4,585 | +48.1% | 0.00% | – |
| Q3 2019 | $110,000 | -26.2% | 3,095 | -36.6% | 0.00% | – |
| Q2 2019 | $149,000 | -65.2% | 4,883 | -73.4% | 0.00% | – |
| Q1 2019 | $428,000 | +415.7% | 18,362 | +202.1% | 0.00% | – |
| Q4 2018 | $83,000 | -73.0% | 6,079 | -80.3% | 0.00% | – |
| Q3 2018 | $307,000 | – | 30,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,162,671 | $43,989,000 | 2.86% |
| Foresite Capital Management IV, LLC | 245,082 | $4,985,000 | 1.70% |
| Cormorant Asset Management, LP | 385,846 | $7,455,000 | 0.55% |
| Monashee Investment Management LLC | 125,000 | $2,543,000 | 0.48% |
| Perceptive Advisors | 686,922 | $13,971,000 | 0.37% |
| Board of Trustees of The Leland Stanford Junior University | 179,072 | $3,642,000 | 0.35% |
| DC Investments Management, LLC | 25,952 | $528,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 323,807 | $6,586,000 | 0.23% |
| VIKING GLOBAL INVESTORS LP | 1,986,201 | $40,399,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 49,833 | $1,014,000 | 0.16% |